steroplast healthcare limited

steroplast healthcare limited Company Information

Share STEROPLAST HEALTHCARE LIMITED
Live 
MatureMidDeclining

Company Number

00504340

Industry

Non-specialised wholesale trade

 

Other manufacturing n.e.c.

 

Shareholders

adam carter brown

mark doncaster brown

Group Structure

View All

Contact

Registered Address

alpha point, bradnor road, manchester, M22 4TE

steroplast healthcare limited Estimated Valuation

£3.5m

Pomanda estimates the enterprise value of STEROPLAST HEALTHCARE LIMITED at £3.5m based on a Turnover of £5.3m and 0.66x industry multiple (adjusted for size and gross margin).

steroplast healthcare limited Estimated Valuation

£0

Pomanda estimates the enterprise value of STEROPLAST HEALTHCARE LIMITED at £0 based on an EBITDA of £-1m and a 5.25x industry multiple (adjusted for size and gross margin).

steroplast healthcare limited Estimated Valuation

£3.6m

Pomanda estimates the enterprise value of STEROPLAST HEALTHCARE LIMITED at £3.6m based on Net Assets of £2.1m and 1.72x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Steroplast Healthcare Limited Overview

Steroplast Healthcare Limited is a live company located in manchester, M22 4TE with a Companies House number of 00504340. It operates in the other manufacturing n.e.c. sector, SIC Code 32990. Founded in March 1952, it's largest shareholder is adam carter brown with a 95.2% stake. Steroplast Healthcare Limited is a mature, mid sized company, Pomanda has estimated its turnover at £5.3m with declining growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Steroplast Healthcare Limited Health Check

Pomanda's financial health check has awarded Steroplast Healthcare Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 7 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating3out of 5
positive_score

2 Strong

positive_score

3 Regular

positive_score

7 Weak

size

Size

annual sales of £5.3m, make it smaller than the average company (£13.5m)

£5.3m - Steroplast Healthcare Limited

£13.5m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of -1%, show it is growing at a slower rate (4.7%)

-1% - Steroplast Healthcare Limited

4.7% - Industry AVG

production

Production

with a gross margin of 28.6%, this company has a comparable cost of product (28.6%)

28.6% - Steroplast Healthcare Limited

28.6% - Industry AVG

profitability

Profitability

an operating margin of -20.3% make it less profitable than the average company (5.9%)

-20.3% - Steroplast Healthcare Limited

5.9% - Industry AVG

employees

Employees

with 31 employees, this is below the industry average (53)

31 - Steroplast Healthcare Limited

53 - Industry AVG

paystructure

Pay Structure

on an average salary of £40.8k, the company has an equivalent pay structure (£40.8k)

£40.8k - Steroplast Healthcare Limited

£40.8k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £171.5k, this is less efficient (£263.8k)

£171.5k - Steroplast Healthcare Limited

£263.8k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 57 days, this is near the average (56 days)

57 days - Steroplast Healthcare Limited

56 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 33 days, this is quicker than average (40 days)

33 days - Steroplast Healthcare Limited

40 days - Industry AVG

stockdays

Stock Days

it holds stock equivalent to 129 days, this is more than average (73 days)

129 days - Steroplast Healthcare Limited

73 days - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 26 weeks, this is more cash available to meet short term requirements (14 weeks)

26 weeks - Steroplast Healthcare Limited

14 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 23.7%, this is a lower level of debt than the average (48.5%)

23.7% - Steroplast Healthcare Limited

48.5% - Industry AVG

STEROPLAST HEALTHCARE LIMITED financials

EXPORTms excel logo

Steroplast Healthcare Limited's latest turnover from March 2023 is estimated at £5.3 million and the company has net assets of £2.1 million. According to their latest financial statements, Steroplast Healthcare Limited has 31 employees and maintains cash reserves of £296.2 thousand as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010
Turnover5,316,6745,330,5844,479,9165,421,7925,427,7245,030,9825,394,1355,105,1695,615,6945,443,4474,868,7644,491,9174,178,1234,124,850
Other Income Or Grants00000000000000
Cost Of Sales3,798,9503,801,0283,242,7003,884,0873,880,1163,586,5713,787,1623,560,4673,947,9593,812,8673,403,2873,138,9402,910,5602,863,265
Gross Profit1,517,7241,529,5571,237,2161,537,7051,547,6081,444,4101,606,9731,544,7021,667,7351,630,5801,465,4771,352,9761,267,5631,261,585
Admin Expenses2,599,0591,318,4711,107,2191,510,2811,360,0551,406,9091,547,2711,524,8311,465,6531,439,8021,423,781989,837949,017-1,111,039
Operating Profit-1,081,335211,086129,99727,424187,55337,50159,70219,871202,082190,77841,696363,139318,5462,372,624
Interest Payable04,32412,73818,27821,57322,03110,8890000000
Interest Receivable17,6655,0867285592,2091,1607608187335387691,3971,182554
Pre-Tax Profit-1,063,670211,848117,9869,705168,18916,63049,57320,689202,815191,31742,466364,536319,7282,373,178
Tax0-40,251-22,417-1,844-31,956-3,160-9,914-4,138-42,591-44,003-10,192-94,779-89,524-664,490
Profit After Tax-1,063,670171,59795,5697,861136,23313,47039,65816,551160,224147,31432,274269,757230,2041,708,688
Dividends Paid00000000000000
Retained Profit-1,063,670171,59795,5697,861136,23313,47039,65816,551160,224147,31432,274269,757230,2041,708,688
Employee Costs1,265,1761,172,0931,141,7151,101,3501,046,3681,087,6881,055,896937,732952,348970,477863,410794,746746,243797,032
Number Of Employees3130313029313128293027252426
EBITDA*-1,022,504259,871190,281112,583220,00637,50162,86289,800268,469256,511109,716416,582386,7982,446,896

* Earnings Before Interest, Tax, Depreciation and Amortisation

Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010
Tangible Assets206,042873,555874,286936,588996,954986,815958,022962,7261,000,932973,3221,000,660926,605898,401928,460
Intangible Assets00000000000000
Investments & Other0402,204401,630401,630400,559396,690388,0450000000
Debtors (Due After 1 year)00000000000000
Total Fixed Assets206,0421,275,7591,275,9161,338,2181,397,5131,383,5051,346,067962,7261,000,932973,3221,000,660926,605898,401928,460
Stock & work in progress1,342,713909,233981,592899,5091,109,2421,216,3931,063,5781,116,5431,026,647981,2941,143,491992,853869,788841,958
Trade Debtors833,7861,027,291685,3501,022,939936,543891,536969,062906,9561,199,1181,096,027884,845810,548751,121669,693
Group Debtors2,7920000000000000
Misc Debtors24,09667,359139,814199,768131,264115,851163,496210,962000000
Cash296,208535,065821,224634,047483,775105,206358,592249,02377,987215,29874307,681251,191221,411
misc current assets00000000000000
total current assets2,499,5952,538,9482,627,9802,756,2632,660,8242,328,9862,554,7282,483,4842,303,7522,292,6192,028,4102,111,0821,872,1001,733,062
total assets2,705,6373,814,7073,903,8964,094,4814,058,3373,712,4913,900,7953,446,2103,304,6843,265,9413,029,0703,037,6872,770,5012,661,522
Bank overdraft0000018,96600000000
Bank loan0027,02121,96219,903018,6630000000
Trade Creditors 351,810335,494284,671550,658650,590366,188657,858549,114631,021746,054627,944664,916660,732721,773
Group/Directors Accounts00000000000000
other short term finances00000000000000
hp & lease commitments9,9818,0501,0266,1507,268000000000
other current liabilities214,763318,772516,074361,396206,818265,084161,766210,907000000
total current liabilities576,554662,316828,792940,166884,579650,238838,287760,021631,021746,054627,944664,916660,732721,773
loans00101,089267,577289,849310,475329,7790000000
hp & lease commitments45,68110,73301,0256,057000000000
Accruals and Deferred Income00000000000000
other liabilities000000004,0259,07432,10632,55460,530121,515
provisions17,67212,25816,21223,47923,47933,63828,05921,17721,17722,57628,09731,56810,3479,546
total long term liabilities63,35322,991117,301292,081319,385344,113357,83821,17725,20231,65060,20364,12270,877131,061
total liabilities639,907685,307946,0931,232,2471,203,964994,3511,196,125781,198656,223777,704688,147729,038731,609852,834
net assets2,065,7303,129,4002,957,8032,862,2342,854,3732,718,1402,704,6702,665,0122,648,4612,488,2372,340,9232,308,6492,038,8921,808,688
total shareholders funds2,065,7303,129,4002,957,8032,862,2342,854,3732,718,1402,704,6702,665,0122,648,4612,488,2372,340,9232,308,6492,038,8921,808,688
Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010
Operating Activities
Operating Profit-1,081,335211,086129,99727,424187,55337,50159,70219,871202,082190,77841,696363,139318,5462,372,624
Depreciation58,83148,78560,28485,15932,45303,16069,92966,38765,73368,02053,44368,25274,272
Amortisation00000000000000
Tax0-40,251-22,417-1,844-31,956-3,160-9,914-4,138-42,591-44,003-10,192-94,779-89,524-664,490
Stock433,480-72,35982,083-209,733-107,151152,815-52,96589,89645,353-162,197150,638123,06527,830841,958
Debtors-233,976269,486-397,543154,90060,420-125,17114,640-81,200103,091211,18274,29759,42781,428669,693
Creditors16,31650,823-265,987-99,932284,402-291,670108,744-81,907-115,033118,110-36,9724,184-61,041721,773
Accruals and Deferred Income-104,009-197,302154,678154,578-58,266103,318-49,141210,907000000
Deferred Taxes & Provisions5,414-3,954-7,2670-10,1595,5796,8820-1,399-5,521-3,47121,2218019,546
Cash flow from operations-1,304,287-127,940364,748220,218450,758-176,076157,758205,966-38,998276,112-165,854164,716127,7761,002,074
Investing Activities
capital expenditure608,682-48,0542,018-24,793-42,592-28,7931,544-31,723-93,997-38,395-142,075-81,647-38,193-1,002,732
Change in Investments-402,20457401,0713,8698,645388,0450000000
cash flow from investments1,010,886-48,6282,018-25,864-46,461-37,438-386,501-31,723-93,997-38,395-142,075-81,647-38,193-1,002,732
Financing Activities
Bank loans0-27,0215,0592,05919,903-18,66318,6630000000
Group/Directors Accounts00000000000000
Other Short Term Loans 00000000000000
Long term loans0-101,089-166,488-22,272-20,626-19,304329,7790000000
Hire Purchase and Lease Commitments36,87917,757-6,149-6,15013,325000000000
other long term liabilities0000000-4,025-5,049-23,032-448-27,976-60,985121,515
share issue0000000000000100,000
interest17,665762-12,010-17,719-19,364-20,871-10,1298187335387691,3971,182554
cash flow from financing54,544-109,591-179,588-44,082-6,762-58,838338,313-3,207-4,316-22,494321-26,579-59,803222,069
cash and cash equivalents
cash-238,857-286,159187,177150,272378,569-253,386109,569171,036-137,311215,224-307,60756,49029,780221,411
overdraft0000-18,96618,96600000000
change in cash-238,857-286,159187,177150,272397,535-272,352109,569171,036-137,311215,224-307,60756,49029,780221,411

steroplast healthcare limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for steroplast healthcare limited. Get real-time insights into steroplast healthcare limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Steroplast Healthcare Limited Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for steroplast healthcare limited by selecting its closest rivals, whether from the MANUFACTURING sector, other mid companies, companies in M22 area or any other competitors across 12 key performance metrics.

steroplast healthcare limited Ownership

STEROPLAST HEALTHCARE LIMITED group structure

Steroplast Healthcare Limited has no subsidiary companies.

Ultimate parent company

STEROPLAST HEALTHCARE LIMITED

00504340

STEROPLAST HEALTHCARE LIMITED Shareholders

adam carter brown 95.22%
mark doncaster brown 4.78%

steroplast healthcare limited directors

Steroplast Healthcare Limited currently has 2 directors. The longest serving directors include Mr Adam Brown (Jul 1997) and Mr Mohammed Ramzan (Nov 2002).

officercountryagestartendrole
Mr Adam BrownUnited Kingdom61 years Jul 1997- Director
Mr Mohammed Ramzan53 years Nov 2002- Director

P&L

March 2023

turnover

5.3m

0%

operating profit

-1.1m

0%

gross margin

28.6%

-0.51%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

March 2023

net assets

2.1m

-0.34%

total assets

2.7m

-0.29%

cash

296.2k

-0.45%

net assets

Total assets minus all liabilities

steroplast healthcare limited company details

company number

00504340

Type

Private limited with Share Capital

industry

46900 - Non-specialised wholesale trade

32990 - Other manufacturing n.e.c.

incorporation date

March 1952

age

72

incorporated

UK

ultimate parent company

None

accounts

Total Exemption Full

last accounts submitted

March 2023

previous names

steroplast ltd (March 2009)

adhesive fabrics (manchester) limited (May 1988)

accountant

-

auditor

-

address

alpha point, bradnor road, manchester, M22 4TE

Bank

-

Legal Advisor

-

steroplast healthcare limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 9 charges/mortgages relating to steroplast healthcare limited. Currently there are 2 open charges and 7 have been satisfied in the past.

charges

steroplast healthcare limited Companies House Filings - See Documents

datedescriptionview/download